Navigation Links
Eisai is Granted Favorable Preliminary Injunction Ruling in Aricept(R) Patent Infringement Lawsuit Against Teva Pharmaceuticals
Date:3/28/2008

EF="http://www.eisai.co.jp/index-e.html" target="_new">http://www.eisai.co.jp/index-e.html.

About Eisai Inc.

Eisai Inc. is a U.S. pharmaceutical subsidiary of Eisai Co., Ltd. Established in 1995, Eisai Inc. began marketing its first product in the United States in 1997 and has rapidly grown to become an integrated pharmaceutical business with sales of approximately $2.6 billion in fiscal year 2006 (year ended March 31, 2007). For more information about Eisai Inc., please visit http://www.eisai.com.

About Aricept(R)

Aricept(R) is well tolerated but may not be for everyone. People at risk for stomach ulcers or who take certain other medicines should tell their doctors because serious stomach problems, such as bleeding, may get worse. Some people who take Aricept(R) may experience fainting. Some people may have nausea, vomiting, diarrhea, bruising, or not sleep well. Some people may have muscle cramps or loss of appetite or may feel tired. In studies, these were usually mild and temporary.

In a progressively degenerative disease such as Alzheimer's, improvement, stabilization or a less-than-expected decline over time is considered a positive response to treatment. These types of responses have been observed in patients treated with Aricept(R) in clinical trials for Alzheimer's disease. Individual responses to treatment vary. For more information about Aricept(R), see accompanying full prescribing information or call (888) 999-9616 or visit http://www.aricept.com.

Safe Harbor Statement

This press release may contain so-called "forward-looking statements." These statements are based on current expectations, forecasts and assumptions that are subject to risks and uncertainties which could cause actual outcomes and results to differ materially from these statements. Risks and uncertainties include general industry and mark
'/>"/>

SOURCE Eisai Co., Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Eisai/Pfizers Aricept Owns a Dominating 42.4% Patient Share for First-Line Treatment of Alzheimers Disease
2. Eisai Announces Change in U.S. Submission Schedule for E7389 New Drug Application
3. U.S. District Court Decision About Eisais Legal Action Over Aricept ODT(R) ANDA Filing
4. TorreyPines Therapeutics and Eisai Co., Ltd. Extend Genetics Discovery Collaboration for Alzheimers Disease
5. Genta Granted Extension to Achieve Compliance with NASDAQ Listing Requirements
6. Neptune Technologies patent granted for novel phospholipids in multiple diseases and pharmaceutical applications
7. Kiwa Bio-Tech New Bio-Fertilizer Product Granted Initial Fertilizer Registration Certificate By Ministry of Agriculture of the PRC
8. Mpex Candidate, MP-376, Granted U.S. Orphan Drug Status for the Treatment of Cystic Fibrosis
9. Odyssey Thera Granted U.S. Patent for Animal Imaging
10. ISTO Technologies Granted Key Patent for Cartilage Cell Expansion by the United States Patent Office
11. Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Hodgkins Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2008)...e EuroPCR08 will highlight choice of different mod...imaging platform., SAN DIEGO, and BRUSSELS, Belgi...ration (Nasdaq: VOLC ), a leading manufacturer an...nctional measurement (FM) and Optical,Coherence To...agnosis and,treatment of coronary and peripheral v...
(Date:5/12/2008)... PARSIPPANY, N.J., May 12 /...based pharmaceutical company, and,Daiichi Sankyo, ...ir,co-promotion agreement for AZOR(TM)* (amlodipin...d-dose combination of two antihypertensives, the,c... angiotensin receptor,blocker olmesartan medoxomil...
(Date:5/12/2008)...- Conference Call at 10:30 a.m. ET, May 13 -, EME...Neurobiological,Technologies, Inc. (NTI(R)) (Nasda...ts fiscal third quarter and the nine months ended ...ded March 31, 2008 were $3.7 million,compared to $... Research and development expenses were $5.9 milli...
(Date:5/9/2008)...mit ultrashort pulses of light are used for numero...py, laser eye surgery, spectroscopy and controllin...ts is limited by distortions caused by lenses and ...rimental instrumentation. , To better understan...itute of Technology developed the first device to ...
Breaking Biology Technology:Volcano Announces Placement of 1,000th s5 and s5i IVUS Imaging System 2Volcano Announces Placement of 1,000th s5 and s5i IVUS Imaging System 3Volcano Announces Placement of 1,000th s5 and s5i IVUS Imaging System 4Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement 2Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement 3Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement 4Neurobiological Technologies Reports Third Quarter Financial Results 2Neurobiological Technologies Reports Third Quarter Financial Results 3Neurobiological Technologies Reports Third Quarter Financial Results 4Neurobiological Technologies Reports Third Quarter Financial Results 5New technique measures ultrashort laser pulses at focus 2New technique measures ultrashort laser pulses at focus 3
...BI Life Sciences , a division of Quintessence Bio...ife science research, has received a $130,000 Phas... to create absorption profiles for early drug-stag...that it could help researchers and pharmaceutical ...s by various organs quickly and more cost-effectiv...
...Dr. Jamie Thomson and his colleagues at Madison,s ...ear they had developed two new lines of stem cells...teins. The breakthrough was hailed in scientific c...closer to clinical trials. , ,But there was a catc...stem cell lines from previously approved colonies ...
...dary this week: I have a number of juicy topics I ...ticipation in the annual Israel biotech/medical de...n in meetings about India and my growing insights ...n, and other research that has crossed my transom ...k on why I originally wanted to start writing this...
...early a week since its first notification, TDS Te...sin, including several served by TDS, are still be...gnificant reductions in long distance calling plan...ilar to online "Phishing" schemes. , ,As part of a...ent discount on their long-distance service and ar...
Other Biology Technology:QBI Life Sciences snags $130,000 NIH grant 2Why the Senate should ease stem cell restrictions 2Why the Senate should ease stem cell restrictions 3The world of in-vitro diagnostics is another Midwest success story 2The world of in-vitro diagnostics is another Midwest success story 3The world of in-vitro diagnostics is another Midwest success story 4The world of in-vitro diagnostics is another Midwest success story 5The world of in-vitro diagnostics is another Midwest success story 6TDS warns of continuing "Vishing" attempts 2
(Date:5/12/2008)...panish . , Arlington, Virginia (May 12, 2008) ...ogs, have to do it. , In the Cerrado region of B... scent are helping researchers monitor rare and th...eater and maned wolf in and around Emas National P...on of threatened species in Brazil. , The resear...
(Date:5/12/2008)... 20-year study showing that environmental laws ena...reducing overall contaminant levels in coastal wat...tinuing concerns with elevated levels of metals an...rial areas of the coasts. , Its interesting ...al chemicals, such as PCBs, show significant decre...
(Date:5/11/2008)...eady for its role in schizophrenia has been found...port in todays advance on-line issue of Nature. ,...cal Center (BIDMC), the study further suggests tha...agnostic marker and therapeutic supplement for the..., Characterized by hypertension, proteinuria, and...
(Date:5/9/2008)...n, Enhanced Standards Support and Java ...a, May 7 /PRNewswire/ -- Neurotechnology, a provid...nologies, today announced,the availability of Mega...,automated fingerprint identification systems (AFI...tion systems. MegaMatcher 2.1 includes a number,of...
Breaking Biology News(10 mins):Can feces save the species? 2Can feces save the species? 3NOAA reports coastal waters show decline in contaminants 2NOAA reports coastal waters show decline in contaminants 3A new gene trigger for pregnancy disorder identified 2Neurotechnology Announces MegaMatcher 2.1 SDK for Development of Large-scale AFIS and Multi-biometric Face-Fingerprint Identification Systems 2Neurotechnology Announces MegaMatcher 2.1 SDK for Development of Large-scale AFIS and Multi-biometric Face-Fingerprint Identification Systems 3Neurotechnology Announces MegaMatcher 2.1 SDK for Development of Large-scale AFIS and Multi-biometric Face-Fingerprint Identification Systems 4LifeMasters Strengthens Capital Structure with 2415 Million in Funding from Existing Investors 13978 1LifeMasters Strengthens Capital Structure with 2415 Million in Funding from Existing Investors 13978 2LifeMasters Strengthens Capital Structure with 2415 Million in Funding from Existing Investors 13978 3The Bill 26 Melinda Gates Foundation BIO and Bio Ventures for Global Health Invite Proteome Systems CEO to Speak on TB Diagnostics Solutions At Par 3842 1The Bill 26 Melinda Gates Foundation BIO and Bio Ventures for Global Health Invite Proteome Systems CEO to Speak on TB Diagnostics Solutions At Par 3842 2The Bill 26 Melinda Gates Foundation BIO and Bio Ventures for Global Health Invite Proteome Systems CEO to Speak on TB Diagnostics Solutions At Par 3842 3Abbott Receives CE Mark for Smaller Size XIENCE 28TM 29 V Drug Eluting Stent 13977 1Abbott Receives CE Mark for Smaller Size XIENCE 28TM 29 V Drug Eluting Stent 13977 2Abbott Receives CE Mark for Smaller Size XIENCE 28TM 29 V Drug Eluting Stent 13977 3Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2007 Results 2459 1Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2007 Results 2459 2Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2007 Results 2459 3Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2007 Results 2459 4Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2007 Results 2459 5Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2007 Results 2459 6
...e immune-stimulating hormone known as interleukin-...ron, another immune-system protein, as an experime...eron is used alone to stimulate the immune system ...f immunotherapy, is sometimes used to treat melano...espond poorly to chemotherapy or radiation therapy...
...chnology, chemistry and biology now have access to...in the world. The new Spectral Imaging Facility, o...ce microscope and a laser scanning confocal micros...The atomic force microscope was built by Asylum Re...e system by Olympus America Inc. Integration of th...
...w insights into how neurons control growth of the ...t enable them to connect with their neighbors. Den...s by which neurons form the signaling networks tha...nsights into neuronal growth will help researchers...as well as aid efforts to restore neuronal connect...
...a study in Botswana, Harvard School of Public Heal...ubtype C in resource-poor settings, who receive an... results to those in the developed world. A fully ...ucture help ensure this success, according to data...f Acquired Immune Deficiency Syndromes (JAIDS). , ...
Other Biology News:Study shows combination of immune substances to be safe 2How the neuron sprouts its branches 2How the neuron sprouts its branches 3Largest computational biology simulation mimics life’s most essential nanomachine 2
...2-D gel marker mix was designed specifically to ai...ntains a complement of seven reduced and denatured...o those who use markers to assess 2-D system perfo...of proteins undergoing 2-D separation and analysis...
...is a completely redesigned and updated version of ...ll line of well-proven Alpha heat-pump assemblies....ance as the DNA Engine Dyad, and original Tetrad t...ls among platforms. The Tetrad 2 contains an onboa...
The DNA Engine Tetrad thermal cycler expands the envelope of discovery beyond the pioneering PTC-200 DNA Engine cycler. It has four times the capacity with a footprint only twice the size, providin
ID clarifier: platform
Biology Products: